BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16000558)

  • 1. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
    Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
    Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of SDF-1α/CXCR4 signaling pathway in clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
    Li YL; Li YF; Li HF; Lv HQ; Sun DZ
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28559386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of CXCR4 expression by the ocular microenvironment.
    Li H; Niederkorn JY; Sadegh L; Mellon J; Chen PW
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):234-43. PubMed ID: 23188729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells.
    Ottaiano A; di Palma A; Napolitano M; Pisano C; Pignata S; Tatangelo F; Botti G; Acquaviva AM; Castello G; Ascierto PA; Iaffaioli RV; Scala S
    Cancer Immunol Immunother; 2005 Aug; 54(8):781-91. PubMed ID: 15592929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers.
    Fath MA; Liu D; Ewald JT; Robles-Planells C; Tomanek-Chalkley AM; Graves SA; Howe JR; O'Dorisio TM; Rastogi P; Bellizzi AM; O'Dorisio MS; Menda Y; Spitz DR
    Radiat Res; 2024 Jan; 201(1):35-47. PubMed ID: 37989124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis.
    Wang Y; Kumar S; Rachagani S; Sajja BR; Xie Y; Hang Y; Jain M; Li J; Boska MD; Batra SK; Oupický D
    Biomaterials; 2016 Sep; 101():108-120. PubMed ID: 27267632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HeLa cells cross-contaminated nasopharyngeal carcinoma cell lines: Still a common problem.
    Makowska A; Kontny U; Weiskirchen R
    Br J Cancer; 2024 Apr; ():. PubMed ID: 38664578
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfoconjugation of protein peptides and glycoproteins in physiology and diseases.
    Xu P; Cai X; Guan X; Xie W
    Pharmacol Ther; 2023 Nov; 251():108540. PubMed ID: 37777160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LCS-1 inhibition of superoxide dismutase 1 induces ROS-dependent death of glioma cells and degradates PARP and BRCA1.
    Ling M; Liu Q; Wang Y; Liu X; Jiang M; Hu J
    Front Oncol; 2022; 12():937444. PubMed ID: 35978820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway.
    Xia Y; Wang G; Jiang M; Liu X; Zhao Y; Song Y; Jiang B; Zhu D; Hu L; Zhang Z; Cao T; Wang JM; Hu J
    Onco Targets Ther; 2021; 14():4047-4060. PubMed ID: 34262291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients.
    Fung AS; Kopciuk K; Dean ML; D'Silva A; Otsuka S; Klimowicz A; Hao D; Morris D; Bebb DG
    PLoS One; 2021; 16(1):e0241240. PubMed ID: 33507926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.
    Cao Y; Xie L; Shi F; Tang M; Li Y; Hu J; Zhao L; Zhao L; Yu X; Luo X; Liao W; Bode AM
    Signal Transduct Target Ther; 2021 Jan; 6(1):15. PubMed ID: 33436584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
    Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
    Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.
    Du Q; Tan Z; Shi F; Tang M; Xie L; Zhao L; Li Y; Hu J; Zhou M; Bode A; Luo X; Cao Y
    Cancer Sci; 2019 Jun; 110(6):2050-2062. PubMed ID: 30945396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer.
    Li J; He Y; Tan Z; Lu J; Li L; Song X; Shi F; Xie L; You S; Luo X; Li N; Li Y; Liu X; Tang M; Weng X; Yi W; Fan J; Zhou J; Qiang G; Qiu S; Wu W; Bode AM; Cao Y
    Theranostics; 2018; 8(15):4050-4061. PubMed ID: 30128035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
    Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
    Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy.
    De-Colle C; Mönnich D; Welz S; Boeke S; Sipos B; Fend F; Mauz PS; Tinhofer I; Budach V; Jawad JA; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Bayer C; Belka C; Pigorsch S; Combs SE; Lohaus F; Linge A; Krause M; Baumann M; Zips D; Menegakis A
    Clin Transl Radiat Oncol; 2017 Aug; 5():28-36. PubMed ID: 29594214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 knockdown inhibits the growth and invasion of nasopharyngeal cancer stem cells.
    Tian Y; Song Y; Bai W; Ma X; Ren Z
    Oncol Lett; 2017 Apr; 13(4):2253-2259. PubMed ID: 28454388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of chemokine receptor CXCR4 is closely correlated with clinical outcome in human nasopharyngeal carcinoma.
    Tao H; Wei Y; Wang C; Yang K; Huang W; Liu H; Li B
    Tumour Biol; 2016 May; 37(5):6099-105. PubMed ID: 26611644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-Inflammatory Cytokine IL-1β Up-Regulates CXC Chemokine Receptor 4 via Notch and ERK Signaling Pathways in Tongue Squamous Cell Carcinoma.
    Sun Y; Zhu D; Wang G; Wang D; Zhou H; Liu X; Jiang M; Liao L; Zhou Z; Hu J
    PLoS One; 2015; 10(7):e0132677. PubMed ID: 26176534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.